# Island Pharmaceuticals Ltd — Form D

Island Pharmaceuticals Ltd of CAMBERWELL, C3, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-05. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-06-05
- Form: D
- Accession: 0000898432-24-000462
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 4
- Date of first sale: 2024-03-05
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-515176

## Issuer

- Name: Island Pharmaceuticals Ltd
- CIK: 0002012855
- Entity type: Corporation
- Jurisdiction: AUSTRALIA
- Incorporated: 2020
- Address: SUITE 201, 697 BURKE ROAD, CAMBERWELL, C3, 3124
- Phone: 61390920475

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| David Brookes | Director | Camberwell, C3 |
| David Foster | Director | Camberwell, C3 |
| Albert Hansen | Director | Newport Beach, CA |
| Paul MacLeman | Director | Camberwell, C3 |
| Nick McCoy | Executive Officer | Camberwell, C3 |

## More

- [CIK 2012855 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2012855&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000898432-24-000462.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.